Reversible Inhibitors of LSD1 as Therapeutic Agents in Acute Myeloid Leukemia: Clinical Significance and Progress to Date
出版年份 2014 全文链接
标题
Reversible Inhibitors of LSD1 as Therapeutic Agents in Acute Myeloid Leukemia: Clinical Significance and Progress to Date
作者
关键词
-
出版物
MEDICINAL RESEARCH REVIEWS
Volume 35, Issue 3, Pages 586-618
出版商
Wiley
发表日期
2014-11-24
DOI
10.1002/med.21334
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
- (2014) W Fiskus et al. LEUKEMIA
- Synthesis and biological evaluation of coumarin–1,2,3-triazole–dithiocarbamate hybrids as potent LSD1 inhibitors
- (2014) Xian-Wei Ye et al. MedChemComm
- Protein Recognition by Short Peptide Reversible Inhibitors of the Chromatin-Modifying LSD1/CoREST Lysine Demethylase
- (2013) Marcello Tortorici et al. ACS Chemical Biology
- Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents
- (2013) Ying-Chao Duan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Histone Lysine-specific Demethylase 1 (LSD1) Protein Is Involved in Sal-like Protein 4 (SALL4)-mediated Transcriptional Repression in Hematopoietic Stem Cells
- (2013) Li Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Triazole–Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration
- (2013) Yi-Chao Zheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- High-Throughput Virtual Screening Identifies Novel N′-(1-Phenylethylidene)-benzohydrazides as Potent, Specific, and Reversible LSD1 Inhibitors
- (2013) Venkataswamy Sorna et al. JOURNAL OF MEDICINAL CHEMISTRY
- Amine Oxidation Mediated by Lysine-Specific Demethylase 1: Quantum Mechanics/Molecular Mechanics Insights into Mechanism and Role of Lysine 661
- (2013) Bora Karasulu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Histone lysine demethylases as targets for anticancer therapy
- (2013) Jonas W. Højfeldt et al. NATURE REVIEWS DRUG DISCOVERY
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- The variety of leukemic stem cells in myeloid malignancy
- (2013) D H Wiseman et al. ONCOGENE
- Synthesis and evaluation of 3-amino/guanidine substituted phenyl oxazoles as a novel class of LSD1 inhibitors with anti-proliferative properties
- (2013) Balakrishna Dulla et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Development and evaluation of selective, reversible LSD1 inhibitors derived from fragments
- (2013) James R. Hitchin et al. MedChemComm
- Synthesis and Evaluation of Novel Cyclic Peptide Inhibitors of Lysine-Specific Demethylase 1
- (2013) Isuru R. Kumarasinghe et al. ACS Medicinal Chemistry Letters
- Expanding the Druggable Space of the LSD1/CoREST Epigenetic Target: New Potential Binding Regions for Drug-Like Molecules, Peptides, Protein Partners, and Chromatin
- (2013) James C. Robertson et al. PLoS Computational Biology
- Hyperleukocytosis, leukostasis and leukapheresis: Practice management
- (2012) Chezi Ganzel et al. BLOOD REVIEWS
- The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells
- (2012) William J. Harris et al. CANCER CELL
- The epigenome of AML stem and progenitor cells
- (2012) Jumpei Yamazaki et al. Epigenetics
- LSD1 inhibition: a therapeutic strategy in cancer?
- (2012) James T Lynch et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor
- (2012) Dominica Willmann et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II Trial of Vorinostat With Idarubicin and Cytarabine for Patients With Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- (2012) Guillermo Garcia-Manero et al. JOURNAL OF CLINICAL ONCOLOGY
- Cladribine, But Not Fludarabine, Added to Daunorubicin and Cytarabine During Induction Prolongs Survival of Patients With Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Study
- (2012) Jerzy Holowiecki et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
- (2012) Hagop M. Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- Low Molecular Weight Amidoximes that Act as Potent Inhibitors of Lysine-Specific Demethylase 1
- (2012) Stuart Hazeldine et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation
- (2012) A Sprüssel et al. LEUKEMIA
- An Overview of Phenylcyclopropylamine Derivatives: Biochemical and Biological Significance and Recent Developments
- (2012) Mohammed Naseer Ahmed Khan et al. MEDICINAL RESEARCH REVIEWS
- Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia
- (2012) Tino Schenk et al. NATURE MEDICINE
- The rule of three in AML induction—is cladribine the answer?
- (2012) Frederick R. Appelbaum Nature Reviews Clinical Oncology
- The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
- (2012) Jan J. Cornelissen et al. Nature Reviews Clinical Oncology
- LSD1/CoREST is an allosteric nanoscale clamp regulated by H3-histone-tail molecular recognition
- (2012) R. Baron et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Base-Pair Resolution DNA Methylation Sequencing Reveals Profoundly Divergent Epigenetic Landscapes in Acute Myeloid Leukemia
- (2012) Altuna Akalin et al. PLoS Genetics
- Genomics of Acute Myeloid Leukemia: The Next Generation
- (2012) Laura Riva et al. Frontiers in Oncology
- Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cells
- (2011) Qingsong Zhu et al. AMINO ACIDS
- Screening for lysine-specific demethylase-1 inhibitors using a label-free high-throughput mass spectrometry assay
- (2011) Matthew Plant et al. ANALYTICAL BIOCHEMISTRY
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
- (2011) Kathrin M. Bernt et al. CANCER CELL
- Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1
- (2011) Changmeng Cai et al. CANCER CELL
- Novel Histone Demethylase LSD1 Inhibitors Selectively Target Cancer Cells with Pluripotent Stem Cell Properties
- (2011) J. Wang et al. CANCER RESEARCH
- Catalytic Mechanism Investigation of Lysine-Specific Demethylase 1 (LSD1): A Computational Study
- (2011) Xiangqian Kong et al. PLoS One
- Structurally Designedtrans-2-Phenylcyclopropylamine Derivatives Potently Inhibit Histone Demethylase LSD1/KDM1,,§
- (2010) Shinya Mimasu et al. BIOCHEMISTRY
- Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
- (2010) D. Grimwade et al. BLOOD
- DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
- (2010) Maria E. Figueroa et al. CANCER CELL
- Cytochrome P450-Mediated Epoxidation of 2-Aminothiazole-Based AKT Inhibitors: Identification of Novel GSH Adducts and Reduction of Metabolic Activation through Structural Changes Guided by in Silico and in Vitro Screening
- (2010) Raju Subramanian et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial
- (2010) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
- (2010) Jonathan B. Baell et al. JOURNAL OF MEDICINAL CHEMISTRY
- Biochemical, Structural, and Biological Evaluation of Tranylcypromine Derivatives as Inhibitors of Histone Demethylases LSD1 and LSD2
- (2010) Claudia Binda et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Phosphorylation of histone H3T6 by PKCβI controls demethylation at histone H3K4
- (2010) Eric Metzger et al. NATURE
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
- (2010) Thomas Ernst et al. NATURE GENETICS
- DNMT3AMutations in Acute Myeloid Leukemia
- (2010) Timothy J. Ley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Mutations of polycomb-associated geneASXL1in myelodysplastic syndromes and chronic myelomonocytic leukaemia
- (2009) Véronique Gelsi-Boyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials
- (2009) Keith Wheatley et al. BRITISH JOURNAL OF HAEMATOLOGY
- Epigenetics in cancer
- (2009) S. Sharma et al. CARCINOGENESIS
- LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer
- (2009) Yan Wang et al. CELL
- An operational definition of epigenetics
- (2009) S. L. Berger et al. GENES & DEVELOPMENT
- The molecular biology of mixed lineage leukemia
- (2009) R. K. Slany HAEMATOLOGICA
- ASXL1 Represses Retinoic Acid Receptor-mediated Transcription through Associating with HP1 and LSD1
- (2009) Sang-Wang Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10
- (2009) Franco Mandelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
- (2009) Pierre Fenaux et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
- (2008) M. A. Sanz et al. BLOOD
- Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia
- (2008) M. G. Guenther et al. GENES & DEVELOPMENT
- Characterization of Chemical Libraries for Luciferase Inhibitory Activity
- (2008) Douglas S. Auld et al. JOURNAL OF MEDICINAL CHEMISTRY
- Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: Causes and consequences
- (2008) Sari Hämäläinen et al. LEUKEMIA & LYMPHOMA
- DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
- (2008) Timothy J. Ley et al. NATURE
- DNA methylation landscapes: provocative insights from epigenomics
- (2008) Miho M. Suzuki et al. NATURE REVIEWS GENETICS
- Therapy-Related Myeloid Leukemia
- (2008) Lucy A. Godley et al. SEMINARS IN ONCOLOGY
- LSD1: oxidative chemistry for multifaceted functions in chromatin regulation
- (2008) Federico Forneris et al. TRENDS IN BIOCHEMICAL SCIENCES
- Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25Å
- (2007) Shinya Mimasu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now